Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study
Neurological Sciences · 2025
DOI: 10.1007/s10072-024-07964-0 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Neurological Sciences, 2025. Verfasst von Francesca Bisulli und 21 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Ospedale Bellaria, Via Altura 3, 40139, Bologna, Italy. Hauptthemen laut MEDLINE: COVID-19, Nervous System Diseases, Neurofilament Proteins, S100 Calcium Binding Protein beta Subunit. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alma Mater Studiorum - Università di Bologna.
Abstract (Originalsprache)
Background and aim COVID-19 is associated with neurological complications, termed neuro-COVID, affecting patient outcomes. We aimed to evaluate the association between serum neurofilament light chain (NfL) and S100B biomarkers with the presence of neurological manifestations and functional prognosis in COVID-19 patients.
Methods
A multicenter prospective cohort study was conducted in three hospitals in the Emilia-Romagna region, Italy, from March 2020 to April 2022. Hospitalized patients with PCR-confirmed COVID-19 were enrolled. Serum S100B and NfL levels were measured in the acute or subacute phase after admission. Diagnostic accuracy was assessed using receiver operating characteristic (ROC) analyses. Statistical analyses were performed to evaluate the association between biomarkers, clinical/laboratory variables, and prognosis, specifically focusing on worsening of the modified Rankin Scale (mRS) from admission to discharge.
Results
A total of 279 patients (153 males, median age 76.7 years) were included. Among them, 69 (24.7%) developed neuro-COVID. Serum NfL levels were significantly higher in the neuro-COVID group (median 110 vs 68.3; p = 0.035) and correlated with severe encephalopathy and extracranial neurologic manifestations. The ROC analysis showed low accuracy in the discrimination between the two groups for both NfL and S100B. Key predictors of worsening mRS included mechanical ventilation (OR = 9.56, 95% CI = 1.67–54.75; p = 0.011), severe encephalopathy (OR = 5.10, 95% CI = 1.58–16.19; p = 0.006), and elevated S100B levels (OR = 2.62, 95% CI = 1.10–6.46; p = 0.037).
Conclusions
Serum NfL and S100B biomarkers were not accurate in discriminating neuro-COVID patients, however NfL levels were associated with severe and extracranial neuro-COVID, while S100B with functional outcomes, potentially informing clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Ospedale Bellaria, Via Altura 3, 40139, Bologna, Italy.
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
- IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Ospedale Bellaria, Via Altura 3, 40139, Bologna, Italy. lorenzo.muccioli@gmail.com.
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy. lorenzo.muccioli@gmail.com.
- Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
- Neurophysiology Unit and Epilepsy Centre, Neuroscience Department, AOU Modena, Modena, Italy.
Förderung
- Alma Mater Studiorum - Università di Bologna
Zitieren
APA
Bisulli, F., Muccioli, L., Taruffi, L., Bedin, R., Felici, S., Zenesini, C., Baccari, F., Gentile, M., Orlandi, N., Rossi, S., Nicodemo, M., d'Achille, F., Viale, P., Zaccaroni, S., Lodi, R., Liguori, R., Zini, A., Guarino, M., Cortelli, P., …, & Meletti, S. (2025). Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study. Neurological Sciences. https://doi.org/10.1007/s10072-024-07964-0
Vancouver
Bisulli F, Muccioli L, Taruffi L, Bedin R, Felici S, Zenesini C, et al. Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study. Neurological Sciences. 2025. doi:10.1007/s10072-024-07964-0
BibTeX
@article{Bisulli2025,
author = {Bisulli, Francesca and Muccioli, Lorenzo and Taruffi, Lisa and Bedin, Roberta and Felici, Silvia and Zenesini, Corrado and Baccari, Flavia and Gentile, Mauro and Orlandi, Niccolò and Rossi, Simone and Nicodemo, Marianna and d'Achille, Fabio and Viale, Pierluigi and Zaccaroni, Stefania and Lodi, Raffaele and Liguori, Rocco and Zini, Andrea and Guarino, Maria and Cortelli, Pietro and Lazzarotto, Tiziana and Janigro, Damir and Meletti, Stefano},
title = {Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study},
journal = {Neurological Sciences},
year = {2025},
doi = {10.1007/s10072-024-07964-0}
}
EUVIMED